Approach to the Patient With a Suboptimal Statin Response: Causes and Algorithm for Clinical Management
The Journal of Clinical Endocrinology & Metabolism · 18.08.2023 · 108 (9) · 2424-2434
DOI: 10.1210/clinem/dgad153 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 17.03.2023. Verfasst von Lufan Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Hospital of China Medical University, Shenyang 110001, China. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cardiovascular Diseases, Dyslipidemias, Atherosclerosis. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Heart, Lung, and Blood Institute (to.
Abstract (Originalsprache)
Context
Statins are the lipid-lowering therapy of choice for the prevention of atherosclerotic cardiovascular disease (ASCVD) but their effectiveness in lowering low-density lipoprotein cholesterol (LDL-C) can substantially differ between individuals. In this mini-review, we describe the different causes for a suboptimal statin response and an algorithm for the diagnosis and clinical management of these patients. Evidence Acquisition A PubMed search using the terms “statin resistance,” “statin sensitivity,” “statin pharmacokinetics,” “cardiovascular disease,” and “lipid-lowering therapies” was performed. Published papers in the past 10 years that were relevant to the topic were examined to provide content for this mini-review. Evidence Synthesis Suboptimal lowering of LDL-C by statins is a major problem in the clinical management of patients and limits the value of this therapeutic approach. There are multiple causes of statin hyporesponsiveness with compliance being the most common explanation. Other causes, such as analytical issues with LDL-C measurement and the presence of common lipid disorders (familial hypercholesterolemia, elevated lipoprotein[a] and secondary dyslipidemias) should be excluded before considering primary statin resistance from rare genetic variants in lipoprotein-related or drug-metabolism genes. A wide variety of nonstatin lipid-lowering drugs are now available and can be added to statins to achieve more effective LDL-C lowering.
Conclusions
The evaluation of statin hyporesponsiveness is a multistep process that can lead to the optimization of lipid-lowering therapy for the prevention of ASCVD. It may also lead to the identification of distinct types of dyslipidemias that require specific therapies and/or the genetic screening of family members.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The First Hospital of China Medical University, Shenyang 110001, China.
- Lipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
- Departamento de Endocrinología y Metabolismo de Lípidos, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, Mexico.
- Unidad de Investigación de Enfermedades Metabólicas, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, Mexico.
ORCID-Profile: Anna Wolska, Alan T Remaley
Förderung
- National Heart, Lung, and Blood Institute (to
Zitieren
APA
Sun, L., Wolska, A., Amar, M., Zubirán, R., & Remaley, A. T. (2023). Approach to the Patient With a Suboptimal Statin Response: Causes and Algorithm for Clinical Management. The Journal of Clinical Endocrinology & Metabolism, 108(9), 2424-2434. https://doi.org/10.1210/clinem/dgad153
Vancouver
Sun L, Wolska A, Amar M, Zubirán R, Remaley AT. Approach to the Patient With a Suboptimal Statin Response: Causes and Algorithm for Clinical Management. The Journal of Clinical Endocrinology & Metabolism. 2023;108(9):2424-2434. doi:10.1210/clinem/dgad153
BibTeX
@article{Sun2023,
author = {Sun, Lufan and Wolska, Anna and Amar, Marcelo and Zubirán, Rafael and Remaley, Alan T},
title = {Approach to the Patient With a Suboptimal Statin Response: Causes and Algorithm for Clinical Management},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2023},
volume = {108},
number = {9},
pages = {2424--2434},
doi = {10.1210/clinem/dgad153}
}
EUVIMED